KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Goodwill & Intangibles: 2009-2025

Historic Goodwill & Intangibles for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to $402.7 million.

  • Pacira BioSciences' Goodwill & Intangibles fell 8.54% to $402.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $402.7 million, marking a year-over-year decrease of 8.54%. This contributed to the annual value of $426.0 million for FY2024, which is 34.11% down from last year.
  • According to the latest figures from Q3 2025, Pacira BioSciences' Goodwill & Intangibles is $402.7 million, which was down 9.07% from $442.9 million recorded in Q2 2025.
  • In the past 5 years, Pacira BioSciences' Goodwill & Intangibles registered a high of $769.2 million during Q4 2021, and its lowest value of $190.2 million during Q3 2021.
  • Over the past 3 years, Pacira BioSciences' median Goodwill & Intangibles value was $617.9 million (recorded in 2024), while the average stood at $553.7 million.
  • In the last 5 years, Pacira BioSciences' Goodwill & Intangibles surged by 292.30% in 2021 and then slumped by 34.11% in 2024.
  • Quarterly analysis of 5 years shows Pacira BioSciences' Goodwill & Intangibles stood at $769.2 million in 2021, then dropped by 8.50% to $703.8 million in 2022, then declined by 8.14% to $646.5 million in 2023, then slumped by 34.11% to $426.0 million in 2024, then fell by 8.54% to $402.7 million in 2025.
  • Its last three reported values are $402.7 million in Q3 2025, $442.9 million for Q2 2025, and $456.5 million during Q1 2025.